Biochemistry and Structural Modeling Core
- Institution
- MAYO CLINIC JACKSONVILLE, FL
- Principal investigator
- Gregory Bowman
- Funding
- $591K
- Duration
- 2021–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY (APOE U19 Core B: Biochemistry and Structural Modeling Core) The APOE gene, which encodes the apoE protein, is the strongest genetic risk factor for Alzheimer’s disease (AD). However, it remains unclear how different apoE isoforms impact aging and AD. The overall goal of this U19 proposal is to test the ApoE Cascade Hypothesis (ACH) that the biochemical and structural differences between apoE isoforms initiate their differential effects on a cascade of events at the cellular and systems levels, ultimately impacting aging-related pathogenic conditions including AD. One hurdle to testing this hypothesis is that the field currently lacks a detailed understanding of the biochemical and structural properties of different apoE isoforms in their native, lipid-bound states—called lipoproteins. Core B will provide biochemistry and structural modeling services to support other U19 projects/cores, helping to uncover the biochemical composition and atomically-detailed structures of lipoproteins. Specifically, we will establish standard protocols for isolating lipoproteins and characterizing their size distribution, lipid composition, and post-translational modifications. We will also develop methods for integrating information from molecular dynamics simulations and structural experiments performed in Project 1 to build atomically-detailed models of the ensemble of structures that lipoproteins adopt. The Core will analyze the data generated to identify signatures that are predictive of the impact of different apoE isoforms on aging and AD.
LOADING MOONBASE SCORE
Questions for MAYO CLINIC JACKSONVILLE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of PennsylvaniaNot yet scored
Understanding and controlling protein energy landscapes by combining simulations and experiments
Gregory Bowman · $402K · 2024–2029
- NIH · University of PennsylvaniaNot yet scored
Structural basis for ApoE4-induced Alzheimer's disease
Gregory Bowman · $594K · 2021–2027
- NIH · Mayo Clinic Jacksonville62
C9orf72-mediated features transcriptomic signatures and translational studies for frontotemporal dementia and related disorders
Marka Van Blitterswijk · $788K · 2022–2027